# Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging

> **NCT01522209** · NA · COMPLETED · sponsor: **Asklepios Kliniken Hamburg GmbH** · enrollment: 59 (actual)

## Conditions studied

- Colon Cancer Liver Metastasis
- Contrast Enhances Intraoperative Ultrasound
- Imaging for Liver Cancer
- Imaging for Liver Metastasis

## Interventions

- **PROCEDURE:** Liver Surgery
- **DEVICE:** Contrast Enhanced Ultrasound
- **RADIATION:** CT Scan (standard)
- **RADIATION:** Primovist MRI (3 Tesla)

## Key facts

- **NCT ID:** NCT01522209
- **Lead sponsor:** Asklepios Kliniken Hamburg GmbH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522209, "Detection Rate of Liver Metastases With Contrast Enhanced Intraoperative Ultrasound Compared to Regular Imaging". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01522209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*